George M Bahr


Affiliation: Institut Pasteur de Lille
Country: France


  1. Bahr G, Darcissac E, Casteran N, Amiel C, Cocude C, Truong M, et al. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice. J Virol. 2001;75:6941-52 pubmed
  2. Bahr G. Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide. J Antimicrob Chemother. 2003;51:5-8 pubmed
  3. Bahr G, De La Tribonniere X, Darcissac E, Ajana F, Bocket L, Sissoko D, et al. Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment. J Antimicrob Chemother. 2003;51:1377-88 pubmed
    ..These results warrant further evaluation of extended periods or cycles of murabutide immunotherapy as adjunct to HAART. ..